Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Trolle

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Immunogenetics|May 28, 2014
NetTepi: an integrated method for the prediction of T cell epitopesThomas Trolle, Morten Nielsen
Immunology|February 16, 2018
Predicted MHC peptide binding promiscuity explains MHC class I 'hotspots' of antigen presentation defined by mass spectrometry eluted ligand dataEmma Christine Jappe, Jens Kringelum, Thomas Trolle, et al.
Frontiers in Immunology|November 25, 2022
Benchmarking freely available HLA typing algorithms across varying genes, coverages and typing resolutionsNikolas Hallberg Thuesen, Michael Schantz Klausen, Shyam Gopalakrishnan, et al.
Bioinformatics (Oxford, England)|December 28, 2017
An automated benchmarking platform for MHC class II binding prediction methodsMassimo Andreatta, Thomas Trolle, Zhen Yan, et al.
Immunogenetics|June 12, 2019
Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity dataChristian Garde, Sri H Ramarathinam, Emma C Jappe, et al.
Bioinformatics (Oxford, England)|February 27, 2015
Automated benchmarking of peptide-MHC class I binding predictionsThomas Trolle, Imir G Metushi, Jason A Greenbaum, et al.
Future Oncology (London, England)|September 1, 2022
KEYNOTE - D36: personalized immunotherapy with a neoepitope vaccine, EVX-01 and pembrolizumab in advanced melanomaGeorgina V Long, Pier Francesco Ferrucci, Adnan Khattak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 20, 2016
The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding PreferenceThomas Trolle, Curtis P McMurtrey, John Sidney, et al.
Nature Communications|December 10, 2020
Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy designEmma C Jappe, Christian Garde, Sri H Ramarathinam, et al.
NPJ Vaccines|May 27, 2023
DNA based neoepitope vaccination induces tumor control in syngeneic mouse modelsNadia Viborg, Michail Angelos Pavlidis, Marina Barrio-Calvo, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Immunogenetics|May 28, 2014
NetTepi: an integrated method for the prediction of T cell epitopesThomas Trolle, Morten Nielsen
Immunology|February 16, 2018
Predicted MHC peptide binding promiscuity explains MHC class I 'hotspots' of antigen presentation defined by mass spectrometry eluted ligand dataEmma Christine Jappe, Jens Kringelum, Thomas Trolle, et al.
Frontiers in Immunology|November 25, 2022
Benchmarking freely available HLA typing algorithms across varying genes, coverages and typing resolutionsNikolas Hallberg Thuesen, Michael Schantz Klausen, Shyam Gopalakrishnan, et al.
Bioinformatics (Oxford, England)|December 28, 2017
An automated benchmarking platform for MHC class II binding prediction methodsMassimo Andreatta, Thomas Trolle, Zhen Yan, et al.
Immunogenetics|June 12, 2019
Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity dataChristian Garde, Sri H Ramarathinam, Emma C Jappe, et al.
Bioinformatics (Oxford, England)|February 27, 2015
Automated benchmarking of peptide-MHC class I binding predictionsThomas Trolle, Imir G Metushi, Jason A Greenbaum, et al.
Future Oncology (London, England)|September 1, 2022
KEYNOTE - D36: personalized immunotherapy with a neoepitope vaccine, EVX-01 and pembrolizumab in advanced melanomaGeorgina V Long, Pier Francesco Ferrucci, Adnan Khattak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 20, 2016
The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding PreferenceThomas Trolle, Curtis P McMurtrey, John Sidney, et al.
Nature Communications|December 10, 2020
Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy designEmma C Jappe, Christian Garde, Sri H Ramarathinam, et al.
NPJ Vaccines|May 27, 2023
DNA based neoepitope vaccination induces tumor control in syngeneic mouse modelsNadia Viborg, Michail Angelos Pavlidis, Marina Barrio-Calvo, et al.
Pageof 2